Company and Mission

The company is a fully owned subsidiary of Inncelerex.

Established to provide consultancy and perform CYBERNETIC DIALYSIS service for pharmaceutical companies and drug research organizations.

The goal is to enable new drugs and existing drugs to have a better guidance for use in patients receiving dialysis.

Improve safety and efficacy of drug treatments in patients receiving dialysis.

Address the current gap in drug prescribing information for patients receiving dialysis.